{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:06:17Z","timestamp":1792605977910,"version":"4.5.0"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Hepatitis B virus is an enveloped DNA virus, that infects more than three hundred and sixty million people worldwide and leads to severe chronic liver diseases. Interferon-alpha inducible protein 6 (IFI6) is an IFN-stimulated gene (ISG) whose expression is highly regulated by the stimulation of type I IFN-alpha that restricts various kinds of virus infections by targeting different stages of the viral life cycle. This study aims to investigate the antiviral activity of IFI6 against HBV replication and gene expression. The IFI6 was highly induced by the stimulation of IFN-\u03b1 in hepatoma cells. The overexpression of IFI6 inhibited while knockdown of IFI6 elevated replication and gene expression of HBV in HepG2 cells. Further study determined that IFI6 inhibited HBV replication by reducing EnhII\/Cp of the HBV without affecting liver enriched transcription factors that have significant importance in regulating HBV enhancer activity. Furthermore, deletion mutation of EnhII\/Cp and CHIP analysis revealed 100 bps (1715-1815 nt) putative sites involved in IFI6 mediated inhibition of HBV. Detailed analysis with EMSA demonstrated that 1715-1770 nt of EnhII\/Cp was specifically involved in binding with IFI6 and restricted EnhII\/Cp promoter activity. Moreover, IFI6 was localized mainly inside the nucleus to involve in the anti-HBV activity of IFI6. <jats:italic>In vivo<\/jats:italic> analysis based on the hydrodynamic injection of IFI6 expression plasmid along with HBV revealed significant inhibition of HBV DNA replication and gene expression. Overall, our results suggested a novel mechanism of IFI6 mediated HBV regulation that could develop potential therapeutics for efficient HBV infection treatment.<\/jats:p>","DOI":"10.3389\/fimmu.2021.634937","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T05:08:47Z","timestamp":1617253727000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":62,"title":["The Functional and Antiviral Activity of Interferon Alpha-Inducible IFI6 Against Hepatitis B Virus Replication and Gene Expression"],"prefix":"10.3389","volume":"12","author":[{"given":"Muhammad","family":"Sajid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafiz","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangpeng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Adnan","family":"Shereen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruidong","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaohong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-016-9712-y","article-title":"HBV culture and infectious systems","volume":"10","author":"Hayes","year":"2016","journal-title":"Hepatol Int"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.04.041","article-title":"Hepatitis B virus PreS\/S gene variants: pathobiology and clinical implications","volume":"61","author":"Pollicino","year":"2014","journal-title":"J Hepatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/2020.05.04.076646","article-title":"Hepatitis B virus Core protein nuclear interactome identifies SRSF10 as a host RNA-binding protein restricting HBV RNA production","volume":"16","author":"Chabrolles","year":"2020","journal-title":"PLoS Pathog"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00236-10","article-title":"Inhibition of hepatitis B virus replication by MyD88 involves accelerated degradation of pregenomic RNA and nuclear retention of pre-S\/S RNAs","volume":"84","author":"Li","year":"2010","journal-title":"J Virol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60207-5","article-title":"Hepatitis B virus infection","volume":"373","author":"Liaw","year":"2009","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s12250-014-3410-5","article-title":"New therapeutic vaccination strategies for the treatment of chronic hepatitis B","volume":"29","author":"Liu","year":"2014","journal-title":"Virol Sin"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29479","article-title":"Epigenetic regulation of hepatitis B virus covalently closed circular DNA: implications for epigenetic therapy against chronic hepatitis B","volume":"66","author":"Hong","year":"2017","journal-title":"Hepatology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JVI.01607-18","article-title":"HoxA10 facilitates SHP-1-catalyzed dephosphorylation of p38 MAPK\/STAT3 to repress hepatitis B virus replication by a feedback regulatory mechanism","volume":"93","author":"Yang","year":"2019","journal-title":"J Virol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e00049","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"Elife"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.23916","article-title":"Recent insights into hepatitis B virus\u2013host interactions","volume":"86","author":"Ezzikouri","year":"2014","journal-title":"J Med Virol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2015.02.031","article-title":"Molecular biology of hepatitis B virus infection","volume":"479","author":"Seeger","year":"2015","journal-title":"Virology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.00835-18","article-title":"Novel potent capsid assembly modulators regulate multiple steps of the hepatitis B virus life cycle","volume":"62","author":"Lahlali","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JVI.01788-17","article-title":"TIP60 complex inhibits hepatitis B virus transcription","volume":"92","author":"Nishitsuji","year":"2018","journal-title":"J Virol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.6.2721-2729.2002","article-title":"Interaction between STAT-3 and HNF-3 leads to the activation of liver-specific hepatitis B virus enhancer 1 function","volume":"76","author":"Waris","year":"2002","journal-title":"J Virol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.24659","article-title":"Interferon stimulated genes and innate immune activation following infection with hepatitis B and C viruses","volume":"89","author":"Hayes","year":"2017","journal-title":"J Med Virol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.immuni.2012.11.005","article-title":"Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol","volume":"38","author":"Liu","year":"2013","journal-title":"Immunity"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21037\/atm.2017.03.69","article-title":"Alpha-interferon treatment in hepatitis B","volume":"5","author":"Woo","year":"2017","journal-title":"Ann Transl Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2011.393","article-title":"G1P3, an interferon-and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer","volume":"31","author":"Cheriyath","year":"2012","journal-title":"Oncogene"},{"key":"B20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-2164-5-8","article-title":"Identification of a novel gene family that includes the interferon-inducible human genes 6\u201316 and ISG12","volume":"5","author":"Parker","year":"2004","journal-title":"BMC Genomics"},{"key":"B21","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41416-018-0137-3","article-title":"G1P3 (IFI6), a mitochondrial localised antiapoptotic protein, promotes metastatic potential of breast cancer cells through mtROS","volume":"119","author":"Cheriyath","year":"2018","journal-title":"Br J Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2010.0105","article-title":"Emerging roles of FAM14 family members (G1P3\/ISG 6\u201316 and ISG12\/IFI27) in innate immunity and cancer","volume":"31","author":"Cheriyath","year":"2011","journal-title":"J\u00a0Interf Cytokine Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/j.1460-2075.1988.tb02786.x","article-title":"Interferon response element of the human gene 6-16","volume":"7","author":"Porter","year":"1988","journal-title":"EMBO J"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1172\/JCI31122","article-title":"G1P3, an IFN-induced survival factor, antagonizes TRAIL-induced apoptosis in human myeloma cells","volume":"117","author":"Cheriyath","year":"2007","journal-title":"J Clin Invest"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.22.14392-14403.2005","article-title":"Genomic analysis of anti-hepatitis B virus (HBV) activity by small interfering RNA and lamivudine in stable HBV-producing cells","volume":"79","author":"Guo","year":"2005","journal-title":"J Virol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.5808\/GI.2013.11.1.15","article-title":"Association between interferon-inducible protein 6 (IFI6) polymorphisms and hepatitis B virus clearance","volume":"11","author":"Park","year":"2013","journal-title":"Genomics Inform"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.03094-14","article-title":"Inhibition of hepatitis B virus gene expression and replication by hepatocyte nuclear factor 6","volume":"89","author":"Hao","year":"2015","journal-title":"J Virol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.26359","article-title":"The N-terminal ubiquitin-associated domain of Cezanne is crucial for its function to suppress NF-\u03baB pathway","volume":"119","author":"Ji","year":"2018","journal-title":"J Cell Biochem"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e1002159","DOI":"10.1371\/journal.ppat.1002159","article-title":"Effects of interferon-\u03b1\/\u03b2 on HBV replication determined by viral load","volume":"7","author":"Tian","year":"2011","journal-title":"PloS Pathog"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.000159","article-title":"Inhibition of hepatitis B virus by the CRISPR\/Cas9 system via targeting the conserved regions of the viral genome","volume":"96","author":"Liu","year":"2015","journal-title":"J Gen Virol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e1008079","DOI":"10.1371\/journal.ppat.1008079","article-title":"P200 family protein IFI204 negatively regulates type I interferon responses by targeting IRF7 in nucleus","volume":"15","author":"Cao","year":"2019","journal-title":"PloS Pathog"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.24302","article-title":"Interferon-inducible Protein 6-16 (IFI-6-16, ISG16) promotes Hepatitis C virus replication in vitro","volume":"88","author":"Chen","year":"2016","journal-title":"J Med Virol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.13.5069","article-title":"Multiple liver-specific factors bind to the hepatitis B virus core\/pregenomic promoter: trans-activation and repression by CCAAT\/enhancer binding protein","volume":"87","author":"L\u00f3pez-Cabrera","year":"1990","journal-title":"Proc Natl Acad Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.13.6908-6914.2004","article-title":"Regulation of hepatitis B virus core promoter by transcription factors HNF1 and HNF4 and the viral X protein","volume":"78","author":"Zheng","year":"2004","journal-title":"J Virol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0607837103","article-title":"PGC-1\u03b1 controls hepatitis B virus through nutritional signals","volume":"103","author":"Shlomai","year":"2006","journal-title":"Proc Natl Acad Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.98.4.1841","article-title":"Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism","volume":"98","author":"Tang","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.patbio.2009.11.001","article-title":"Pathogenesis of hepatitis B virus infection","volume":"58","author":"Chisari","year":"2010","journal-title":"Pathol Biol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043470","article-title":"Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B","volume":"352","author":"Lau","year":"2005","journal-title":"N Engl J Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.06.054","article-title":"Temporal analysis of early immune responses in patients with acute hepatitis B virus infection","volume":"137","author":"Dunn","year":"2009","journal-title":"Gastroenterology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/j.1365-2893.2006.00732.x","article-title":"Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication","volume":"13","author":"Itsui","year":"2006","journal-title":"J Viral Hepat"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.08.043","article-title":"Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection","volume":"131","author":"Randall","year":"2006","journal-title":"Gastroenterology"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.015388-0","article-title":"ISG15, a ubiquitin-like interferon-stimulated gene, promotes hepatitis C virus production in vitro: Implications for chronic infection and response to treatment","volume":"91","author":"Chen","year":"2010","journal-title":"J Gen Virol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.2.1227-1236.2003","article-title":"Searching for interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes","volume":"77","author":"Wieland","year":"2003","journal-title":"J Virol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0504273102","article-title":"Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids","volume":"102","author":"Wieland","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/hep.510230103","article-title":"Cytokine inhibition of the hepatitis B virus core promoter","volume":"23","author":"Romero","year":"1996","journal-title":"Hepatology"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.6.2684-2691.2001","article-title":"Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein","volume":"75","author":"Gordien","year":"2001","journal-title":"J Virol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80279-7","article-title":"Effect of interferon alpha on hepatitis B virus replication and gene expression in transiently transfected human hepatoma cells","volume":"31","author":"Rang","year":"1999","journal-title":"J Hepatol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23011","article-title":"Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain","volume":"50","author":"Gao","year":"2009","journal-title":"Hepatology"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.14986","article-title":"Antiviral activity of interferon-stimulated gene 20, as a putative repressor binding to hepatitis B virus enhancer II and core promoter","volume":"35","author":"Park","year":"2020","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.634937\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T05:08:49Z","timestamp":1617253729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.634937\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":49,"alternative-id":["10.3389\/fimmu.2021.634937"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.634937","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]},"article-number":"634937"}}